Alopecia Areata Market Poised for Expansion by 2036 as Novel Drug Classes Enter Pipeline
The alopecia areata treatment market is forecast to grow substantially by 2036, driven by rising patient prevalence and an emerging wave of novel therapies. New drug classes including OX40L inhibitors are advancing through development pipelines. Investors in pharmaceutical and biotech sectors are tracking the space as a healthcare growth opportunity.
Salvado•